1. A comparison between on-demand usage of rFVIIa vs prophylaxis use of emicizumab in high titer inhibitory hemophilia A patients in Iran: A cost–utility analysis. Issue 40 (8th October 2021) Authors: Saiyarsarai, Parisa; Robabpour Derakhshan, Atefeh; Khedmati, Jamaleddin; Eshghi, Peyman; Seyedifar, Meysam Editors: Cruz., Jorddy Neves Journal: Medicine Issue: Volume 100:Issue 40(2021) Page Start: e27303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A comparison between on-demand usage of rFVIIa vs prophylaxis use of emicizumab in high titer inhibitory hemophilia A patients in Iran: A cost–utility analysis. Issue 40 (8th October 2021) Authors: Saiyarsarai, Parisa; Robabpour Derakhshan, Atefeh; Khedmati, Jamaleddin; Eshghi, Peyman; Seyedifar, Meysam Other Names: Cruz. Jorddy Neves section editor. Journal: Medicine Issue: Volume 100:Issue 40(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study. (25th August 2020) Authors: Tosetto, Alberto; Badiee, Zahra; Baghaipour, Mohammad‐Reza; Baronciani, Luciano; Battle, Javier; Berntorp, Erik; Bodó, Imre; Budde, Ulrich; Castaman, Giancarlo; Eikenboom, Jeroen C. J.; Eshghi, Peyman; Ettorre, Cosimo; Goodeve, Anne; Goudemand, Jenny; Hay, Charles Richard Morris; Hoorfar, Hamid; ... Journal: Journal of thrombosis and haemostasis Issue: Volume 18:Number 9(2020) Page Start: 2145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blood supply sufficiency and safety management in Iran during the COVID‐19 outbreak. Issue 2 (30th September 2020) Authors: Maghsudlu, Mahtab; Eshghi, Peyman; Amini Kafi‐Abad, Sedigheh; Sedaghat, Abbas; Ranjbaran, Hossein; Mohammadi, Saeed; Tabatabai, Seyed Morteza Journal: Vox sanguinis Issue: Volume 116:Issue 2(2021) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical and genetic characteristics of hemoglobin H disease in Iran. (18th August 2022) Authors: Abolghasemi, Hassan; Kamfar, Sharareh; Azarkeivan, Azita; Karimi, Mehran; Keikhaei, Bijan; Abolghasemi, Fahimeh; Radfar, Mohammad H.; Eshghi, Peyman; Alavi, Samin Journal: Pediatric hematology and oncology Issue: Volume 39:Number 6(2022) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. (October 2020) Authors: Abolghasemi, Hassan; Eshghi, Peyman; Cheraghali, Abdol Majid; Imani Fooladi, Abbas Ali; Bolouki Moghaddam, Farzaneh; Imanizadeh, Sina; Moeini Maleki, Matin; Ranjkesh, Mohammad; Rezapour, Mohammad; Bahramifar, Ali; Einollahi, Behzad; Hosseini, Mohammad Javad; Jafari, Nematollah Joneidi; Nikpouragh... Journal: Transfusion and apheresis science Issue: Volume 59:Number 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study. Issue 5 (19th June 2017) Authors: Azizi, Gholamreza; Abolhassani, Hassan; Mahdaviani, Seyed Alireza; Chavoshzadeh, Zahra; Eshghi, Peyman; Yazdani, Reza; Kiaee, Fatemeh; Shaghaghi, Mohammadreza; Mohammadi, Javad; Rezaei, Nima; Hammarström, Lennart; Aghamohammadi, Asghar Journal: Pediatric allergy and immunology Issue: Volume 28:Issue 5(2017) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Coronavirus disease 2019 (COVID‐19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO). Issue 7 (20th April 2020) Authors: Mohammadi, Saeed; Tabatabaei Yazdi, Seyed Morteza; Eshghi, Peyman; Norooznezhad, Amir Hossein Journal: Vox sanguinis Issue: Volume 115:Issue 7(2020) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19. (April 2022) Authors: Fazeli, Alieh; Sharifi, Shahin; Behdad, Fatemeh; Okati, Shamsi; Esmaielifar, Gilda; Jelveh, Nooshin; Eshghi, Peyman; Mohammadi, Saeed Journal: Transfusion and apheresis science Issue: Volume 61:Number 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway. (20th October 2020) Authors: Salimi, Ahmad; Aghvami, Marjan; Azami Movahed, Mahsa; Zarei, Mohammad Hadi; Eshghi, Peyman; Zarghi, Afshin; Pourahmad, Jalal Journal: Cancer investigation Issue: Volume 38:Number 8/9(2020) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗